SEC Form 4 · accession 0001179110-16-031995
MOMENTA PHARMACEUTICALS INC · MNTA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Bruce Leicher
Officer — SVP & General Counsel
Period of report
Nov 21, 2016
Accepted (ET)
Nov 23, 2016 · 10:32 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001235010
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Nov 21, 2016 | S | 416 | $13.45 | D | 183,190 | D | |
| Common Stock | Nov 21, 2016 | S | 387 | $13.45 | D | 182,803 | D | |
| Common Stock | Nov 22, 2016 | S | 227 | $14.40 | D | 182,576 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 27, 2008.
- F2This balance of shares beneficially owned reflects 654 shares acquired under the employee stock plan at a purchase price of $9.57 per share on July 31, 2016.